Globus Medical, Inc. reaffirmed net sales guidance for the year 2022. The company reaffirmed its full year 2022 guidance of $1.025 billion in net sales.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
66.45 USD | -0.37% | +1.33% | +24.53% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+24.53% | 9.01B | |
-6.33% | 179B | |
+0.57% | 108B | |
-2.14% | 69.03B | |
-6.79% | 45.83B | |
+12.26% | 45.39B | |
+8.60% | 43.17B | |
+15.88% | 29.89B | |
+13.65% | 25.49B | |
-8.70% | 23.95B |
- Stock Market
- Equities
- GMED Stock
- News Globus Medical, Inc.
- Globus Medical, Inc. Reaffirms Net Sales Guidance for the Year 2022